but in the meantime we have a buying opportunity today.. unless MAG receives assay results or the cores late yesterday showed something that may send insiders on buying spree.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
